Delivery Order SPE2DR25D1022-SPE2DR26FQT2B
Award Date 12/30/25
Potential Completion Date 1/22/26
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Tecvayli 153 mg/1.7 mL vials. This firm fixed price delivery order, valued at $11,868.12, represents a competitively awarded non-set-aside procurement with an ultimate completion date of September 18, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23.7K delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TECVAYLI 153 MG/1.7 ML vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply requirements through the agency's...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $23,824.28 contract is for the supply of the specialized pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a completion date of March 8, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TECVAYLI 153 mg/1.7 ml vials valued at $11,868.12 on July 29, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. TECVAYLI is a specialty pharmaceutical product reflecting the Defense Logistics Agency's ongoing procurement of specialized...
- This federal contract award, valued at $1,141.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product, to support defense and military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,736.24, is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a specialty medication. The contract has an ultimate completion date of March 17, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation indicated for this award. Amerisourcebergen holds a...
- This federal contract award, valued at $2,283.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tecvayli 30 mg/3 ml vials, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $34,018.40 on September 22, 2025, for the supply of Tecentriq 840 mg/14 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tecentriq is a specialized oncology pharmaceutical product, reflecting the company's role as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,417.25 by the Defense Logistics Agency on December 16, 2025, for the supply of Trodelvy 180 mg vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of January 8, 2026. Performance will be conducted at the company's Conshohocken facility, supporting...
- The Defense Logistics Agency awarded a $17,009.24 delivery order to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 ml vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical...